The result revealed that, as a widespread neuroinflammatory target, S1PR1 in brain areas was positively associated with AD cognitive and memory behavior impairment; the higher the S1PR1 expressed the longer the platform latency period (the time taken to find the platform), especially in the cortex and hippocampus. This evidence concerns the gene S1PR1 and Alzheimer disease.